Combination compositions of camptothecins and fluoropyrimidines

Details for Australian Patent Application No. 2004226889 (hide)

Owner Celator Pharmaceuticals, Inc.

Inventors Johnstone, Sharon; Tardi, Paul; Mayer, Lawrence; Bally, Marcel; Webb, Murray

Agent Shelston IP

Pub. Number AU-B-2004226889

PCT Pub. Number WO2004/087115

Priority 60/460,169 02.04.03 US

Filing date 2 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 20 December 2007

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087115 Priority application(s): WO2004/087115

16 August 2007 Change of Name(s) of Applicant(s), Section 104

  Celator Technologies Inc. The name of the applicant has been changed to Celator Pharmaceuticals, Inc.

20 December 2007 Application Accepted

  Published as AU-B-2004226889

17 April 2008 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226898-Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof

2004226888-Nano-sized vehicles transporting a therapeutic agent and at least one drug resistance modulator for the treatment of multi drug resistance